SC
Suresh Chhabildas Shah
About Suresh Chhabildas Shah
Data last updated:
Suresh Chhabildas Shah is a Director at Mepro Pharmaceuticals Private Limited (since 1982) and Whole-Time Director at Mepromax Life Sciences Private Limited (since 2006). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹439 Cr; the largest is Mepro Pharmaceuticals Private Limited at ₹356 Cr (FY 2025). Earlier, Suresh Chhabildas Shah was a Director at Bdr Pharmaceuticals International Private Limited (2004–2011) and Director at Midland Pharmaceuticals Private Limited (from 1987).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Aug 1982 | 1982 | ₹356 Cr (FY 2025) | Active | |
| Whole-Time Director | 15 Jun 2006 | 2005 | ₹82.29 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Jan 2004 | 2002 | ₹1,137 Cr (FY 2025) | Active | |
| Director | 17 Aug 1987 | 1987 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Suresh Chhabildas Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bharatkumar Chabildas Shah | 00867909 | Mepro Pharmaceuticals Private Limited , Mepromax Life Sciences Private Limited | Director |
| Prakash Navinchandra Shah | 00641718 | Mepro Pharmaceuticals Private Limited , Mepromax Life Sciences Private Limited | Director |
| Rajesh Sumanlal Shah | 00821466 | Mepro Pharmaceuticals Private Limited , Mepromax Life Sciences Private Limited | Director |
| Vijay Chhabildas Shah | 00453308 | Mepro Pharmaceuticals Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Chhabildas Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Chhabildas Shah
Suresh Chhabildas Shah currently holds 2 directorships: Mepro Pharmaceuticals Private Limited (Director, since 31 Aug 1982, revenue ₹356 Cr (FY 2025)); Mepromax Life Sciences Private Limited (Whole-Time Director, since 15 Jun 2006, revenue ₹82.29 Cr (FY 2025)).
Suresh Chhabildas Shah was first appointed on 31 Aug 1982 as Director at Mepro Pharmaceuticals Private Limited. The most recent appointment on record is 15 Jun 2006 at Mepromax Life Sciences Private Limited.
The 2 current companies of Suresh Chhabildas Shah that report revenue have a combined latest revenue of ₹439 Cr: Mepro Pharmaceuticals Private Limited ₹356 Cr (FY 2025); Mepromax Life Sciences Private Limited ₹82.29 Cr (FY 2025).
Suresh Chhabildas Shah held 2 earlier board appointments: Bdr Pharmaceuticals International Private Limited (Director, 05 Jan 2004 to 27 Jul 2011); Midland Pharmaceuticals Private Limited (Director, from 17 Aug 1987).
The current boards of Suresh Chhabildas Shah's companies include Bharatkumar Chabildas Shah (Mepro Pharmaceuticals Private Limited), Prakash Navinchandra Shah (Mepro Pharmaceuticals Private Limited), Rajesh Sumanlal Shah (Mepro Pharmaceuticals Private Limited), Vijay Chhabildas Shah (Mepro Pharmaceuticals Private Limited).